Alpha 1 Global

Our mission is to develop a collaborative global network of Alpha-1 patient leaders, physicians, and researchers, to increase awareness, detection, and access to care for Alphas around the world.


Arrowhead’s ARC-AAT Granted EMA Orphan Drug Designation

PASADENA, Calif. — Arrowhead Research Corporation, a biopharmaceutical company that is developing targeted gene therapies, today announced that the European Medicines Agency (EMA) has granted …

Read More

Skyrocketing Drug Prices Leave Cures Out of Reach for Some Patients

Sophisticated drugs are opening the door, scientists say, to an era of “precision medicine.” They’re also ushering in an age of astronomical prices. New cancer …

Read More

FDA releases Video and Transcript of Meeting on Alpha-1

The U.S. Food and Drug Administration (FDA) has posted video footage and a full transcript of its Sept. 29, 2015 public meeting to discuss Patient-Focused Drug Development for …

Read More

Alpha-1 Around The Globe

Click on the country flags below to learn more about country specific contact and general information, access to care, and available resources

Join Our Newsletter

Subscribe to stay in touch with the latest in Alpha-1 Global